Researchers found no significant difference in 30-day postoperative complications between patients who received neoadjuvant chemotherapy and those who did not.
from Latest articles from Cancer Therapy Advisor News http://bit.ly/2GIzrOy
from Latest articles from Cancer Therapy Advisor News http://bit.ly/2GIzrOy